SCHEMBL5070022

SCHEMBL5070022

COCNC(=O)c1ccc(-c2ccnc(Nc3cccc(CCO)c3)n2)s1

nearest known ligand 0.55

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
AKT3 Q9Y243 17/20 0.55
IKBKB O14920 2/20 0.42
ABL1 P00519 1/20 0.41
BCR P11274 1/20 0.41
SRC P12931 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2198523 0.84 AKT3 (0.47) AKT3IKBKBABL1BCRSRC
SCHEMBL14500316 0.79 AKT3 (0.52) AKT3ABL1BCRSRC
SCHEMBL12423209 0.79 AKT3 (0.56) AKT3IKBKB
SCHEMBL2200857 0.79 SRC (0.47) AKT3IKBKBABL1BCRSRC
SCHEMBL12423200 0.79 AKT3 (0.61) AKT3IKBKB
SCHEMBL5068267 0.78 IKBKB (0.44) AKT3IKBKBABL1BCRSRC
SCHEMBL13051469 0.78 AKT3 (0.49) AKT3ABL1BCRSRC
SCHEMBL12423373 0.78 AKT3 (0.71) AKT3IKBKBABL1BCRSRC
SCHEMBL14100342 0.78 AKT3 (0.51) AKT3IKBKBABL1BCRSRC
SCHEMBL12423662 0.78 AKT3 (0.61) AKT3ABL1BCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1948647-A1 PYRIMIDINYL-THIOPHENE KINASE MODULATORS SGX Pharmaceuticals, Inc. (US) 2008-07-30 EP disclosed
WO-2007053776-A1 PYRIMIDINYL-THIOPHENE KINASE MODULATORS SGX PHARMACEUTICALS, INC. (US) 2007-05-10 WO disclosed